FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

2964811000001105: Oxybutynin 5mg modified-release tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22279901000001111 Oxybutynin 5mg modified-release tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22280001000001112 Oxybutynin 5mg modified-release tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 5mg modified-release tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Is pack of Oxybutynin hydrochloride 5mg m/r tablet false Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has active ingredient Oxybutynin false Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has VMP Oxybutynin 5mg modified-release tablets true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has VMP Oxybutynin hydrochloride 5mg m/r tablet false Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets 30 tablet Has VMP Oxybutynin 5mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ditropan XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Is a True Oxybutynin 5mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Janssen-Cilag Ltd) 30 tablet Is a True Oxybutynin 5mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a True Oxybutynin 5mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier
Lyrinel XL 5mg tablets (Waymade Healthcare Plc) 30 tablet Is a True Oxybutynin 5mg modified-release tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start